Clinical trial · Observational
Predicting Locally Advanced Rectal Cancer Response to NCT and NCRT With MRI
Predicting Locally Advanced Rectal Cancer Response to NCT and NCRT With MRI, and Comparison of MR Imaging Evaluation Between NCT and NCRT
NCT04392609CI-TRIAL-00045143unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This trial was designed to to study whether there is a difference in MRI image evaluation between NCRT and NCT, and try to build a model to predict the efficacy of neoadjuvant therapy by combining multiple imaging indexes.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| MRI | — | UNRESOLVED | — |
| Rectal Cancer | Malignant Rectal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- pTRG
- timeFrame
- within 2 week after surgery
- description
- pathological tumour regression grading
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1. pathological diagnosis of rectal cancer; 2. received neoadjuvant chemoradiotherapy before surgery; 3. before neoadjuvant therapy and before surgery, the patients received thin and high resolution MRI examination of the rectum. 4. before neoadjuvant therapy, colonoscopy, rectal contrast-enhanced ultrasound or MRI showed that the lower margin of the tumor was within 12cm from the anal margin; 5. pre-neoadjuvant clinical stage II/III (AJCC 7th edition); Exclusion Criteria: 1. simultaneous distant metastatic tumor should be considered at the first diagnosis; 2. patients with distant metastasis were not considered at the initial diagnosis; 3. with other malignant tumors; 4. before neoadjuvant therapy, patients had received other relevant treatments; 5. to undergo palliative surgery or emergency surgery in the course of neoadjuvant therapy;
References
Publications (0)
Data not yet available
No reference posted for this study.